Sudeep Pharma Limited (SUDEEPPHRM) Financial History

Name: Sudeep Pharma Limited (SUDEEPPHRM) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-11-01

Sudeep Pharma Limited (SUDEEPPHRM) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Vadodara, India with about 525 employees. Its market capitalization is roughly ₹122 billion. In the fiscal year ended 2026-03-31, SUDEEPPHRM reported ₹6.4B in revenue and ₹1.7B in net income.

Sudeep Pharma Limited manufactures and sells excipients and specialty ingredients for the pharmaceutical, food, and nutrition industries in India, the United States, and internationally.

Interactive charts & full statements → Open the SUDEEPPHRM valuation workbench →

SUDEEPPHRM Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-09-30	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Revenue	₹7.1B	₹6.4B	₹5.0B	₹4.5B	₹4.3B
Gross Profit	₹4.6B	₹4.0B	₹3.3B	₹2.8B	₹2.4B
Operating Income (EBIT)	₹2.3B	₹2.1B	₹1.8B	₹1.7B	₹839M
Net Income	₹1.9B	₹1.7B	₹1.4B	₹1.3B	₹623M

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SUDEEPPHRM Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Total Revenue	₹2.0B	₹1.6B	₹1.8B	₹1.7B	₹1.6B	—
Gross Profit	₹1.3B	₹1.0B	₹1.2B	₹1.1B	₹1.0B	—
Operating Income (EBIT)	₹679M	₹509M	₹587M	₹561M	₹516M	—
Net Income	₹514M	₹406M	₹489M	₹475M	₹458M	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SUDEEPPHRM Free Cash Flow History

SUDEEPPHRM Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Assets	₹11.7B	₹7.2B	₹5.1B	₹4.2B
Total Liabilities	₹2.8B	₹2.2B	₹1.6B	₹2.0B

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SUDEEPPHRM viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

APLLTD · Alembic Pharmaceuticals Limited — ₹157 billion
JUBLPHARMA · Jubilant Pharmova Limited — ₹150 billion
4521 · Kaken Pharmaceutical Co., Ltd. — JPY 145 billion
NATCOPHARM · NATCO Pharma Limited — ₹144 billion
4534 · Mochida Pharmaceutical Co., Ltd. — JPY 115 billion
AKUMS · Akums Drugs and Pharmaceuticals Limited — ₹113 billion
VIYASH · Viyash Scientific Limited — ₹96 billion
STAR · Strides Pharma Science Limited — ₹95 billion

← SUDARSCHEM All “S” companies SUEC →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.